Remy Research (formerly Remy Peptides) is a retail research peptide vendor based in UAE (Dubai). Reseller. Founded 2026. Key products include Retatrutide, BPC-157.
Listing reviewed October 2026.
Remy Research (formerly Remy Peptides) is a Dubai-based supplier of research-use-only peptides, operated by REMY RESEARCH FOR LABORATORIES CHEMICALS TRADING LLC. It is a reseller, not a manufacturer, stocking pre-filled pens, lyophilised vials and vial kits from four brands (ProPeptide, Remedium Research, ZPHC and Genovare), with a retatrutide-led catalogue. It publishes a library of batch-specific lab reports at remyresearch.com/lab-results: 11 batches tested by Janoshik Analytical or METS Lab (Ajman, UAE), each mapped to the product it covers. Most other catalogue items have no published report. Delivery is within the UAE only, by cold-chain courier. All products are sold for in-vitro laboratory research only, not for human or veterinary use.
Directory assessment: Remy Research (formerly Remy Peptides) is listed as a retail peptide vendor in the peptide supply chain, shipping to United Arab Emirates from UAE (Dubai). This supplier operates as a reseller or distributor, sourcing products from upstream manufacturers rather than running its own synthesis. This profile lists 2 sources for reference. This supplier has a medium confidence score — verification signals are present, but the listing is newer or less documented; perform standard due diligence before engaging.